Literature DB >> 20576373

Auditory function in patients with systemic lupus erythematosus.

Katarzyna Maciaszczyk1, Tomasz Durko, Elżbieta Waszczykowska, Anna Erkiert-Polguj, Anna Pajor.   

Abstract

OBJECTIVE: Patients with systemic lupus erythematosus (SLE) may develop hearing and balance disorders as a result of the immune-mediated inner ear damage due to vasculitis or ototoxicity of drugs used in SLE treatment. The aim of the study was evaluation of the hearing organ disorders in patients with SLE with particular regard to their prevalence and relationship to duration and severity of disease. The severity was assessed from involvement of organs that resulted in poorer SLE outcome, i.e. kidneys and central nervous system (CNS), and from the presence of antibodies associated with unfavourable SLE prognosis.
METHODS: Thirty-five unselected, consecutive patients (33 women, two men, mean age 47.8 years) with SLE diagnosed in compliance to the international diagnostic criteria of the American Rheumatism Association (1982) were enrolled into the study. The control group consisted of 30 otologically healthy persons matched to the SLE group for age and sex. Case history was recorded for all patients from questionnaire data and laryngological examinations were performed, followed by pure-tone, speech and impedance audiometry and auditory brainstem response audiometry (ABR).
RESULTS: In the anamnesis 71.4% of patients reported vertigo, 62.9% headaches, 40% tinnitus, 25.7% hyperacusis, 17.1% hearing loss and 2.9% ear fullness. It was found that SLE patients had a significantly poorer mean hearing thresholds than the control group for all frequencies, except for 500; 2000 and 4000 Hz. Longer ABR latency averages were observed in the group of SLE patients compared to control. Ten patients (28.6%) developed high-frequency and symmetric sensorineural hearing loss (SNHL). Significant positive correlation between mean air-conduction hearing thresholds and SLE duration (r = 0.46, p < 0.001) was found. After taking age into consideration, hearing acuity in SLE was related to duration of disease in younger patients. Furthermore, no relation was seen between hearing level and severity of disease.
CONCLUSIONS: Auditory system involvement ought to be considered as one of elements of the clinical picture of systemic lupus erythematosus while determination of its character, original or secondary, requires further research. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20576373     DOI: 10.1016/j.anl.2010.04.008

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  13 in total

1.  Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study.

Authors:  Georgios K Tsirves; Paraskevi V Voulgari; Eleftherios Pelechas; Asimakis D Asimakopoulos; Alexandros A Drosos
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-30       Impact factor: 2.503

Review 2.  Systemic Lupus Erythematosus and hearing disorders: Literature review and meta-analysis of clinical and temporal bone findings.

Authors:  A Di Stadio; Massimo Ralli
Journal:  J Int Med Res       Date:  2017-02-20       Impact factor: 1.671

3.  Cochlear Histopathologic Findings in Patients With Systemic Lupus Erythematosus: A Human Temporal Bone Study.

Authors:  Shin Kariya; Serdar Kaya; Ömer Hizli; Pelin Hizli; Kazunori Nishizaki; Michael M Paparella; Sebahattin Cureoglu
Journal:  Otol Neurotol       Date:  2016-06       Impact factor: 2.311

4.  The effect of thyroid autoantibody positivity on the functions of internal ear.

Authors:  Akif Gunes; Mehmet Fatih Karakus; Tugba Akin Telli; Nurcan Akbas Gunes; Murad Mutlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-08-18       Impact factor: 2.503

5.  Evaluation of hearing functions in patients with euthyroid Hashimoto's thyroiditis.

Authors:  Ayse Arduc; Serhat Isık; Serpil Allusoglu; Ayse Iriz; Bercem Aycicek Dogan; Celil Gocer; Mazhar Muslim Tuna; Dilek Berker; Serdar Guler
Journal:  Endocrine       Date:  2015-05-12       Impact factor: 3.633

Review 6.  Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.

Authors:  Mariana Postal; Lilian T L Costallat; Simone Appenzeller
Journal:  CNS Drugs       Date:  2011-09-01       Impact factor: 5.749

7.  Prevalence of hearing impairment in patients with rheumatoid arthritis, granulomatosis with polyangiitis (GPA, Wegener's granulomatosis), or systemic lupus erythematosus.

Authors:  Torsten Rahne; Franziska Clauß; Stefan K Plontke; Gernot Keyßer
Journal:  Clin Rheumatol       Date:  2017-04-28       Impact factor: 2.980

Review 8.  Function of the audiovestibular system in children with systemic lupus erythematosus.

Authors:  Ghada Ibrahim Gad; Hanan Abdelateef
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

9.  Hearing loss in patients with systemic lupus erythematosus.

Authors:  Mahnaz Abbasi; Zohreh Yazdi; Amir Mohammad Kazemifar; Zahra Zarin Bakhsh
Journal:  Glob J Health Sci       Date:  2013-06-15

10.  Examination of Hearing in a Rheumatoid Arthritis Population: Role of Extended-High-Frequency Audiometry in the Diagnosis of Subclinical Involvement.

Authors:  Mar Lasso de la Vega; Ithzel Maria Villarreal; Julio Lopez-Moya; Jose Ramon Garcia-Berrocal
Journal:  Scientifica (Cairo)       Date:  2016-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.